These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20705055)

  • 1. Direct observation to chemokine receptor 5 on T-lymphocyte cell surface using fluorescent metal nanoprobes.
    Zhang J; Fu Y; Li G; Nowaczyk K; Zhao RY; Lakowicz JR
    Biochem Biophys Res Commun; 2010 Sep; 400(1):111-6. PubMed ID: 20705055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct observation of chemokine receptors 5 on T-lymphocyte cell surfaces using fluorescent metal nanoprobes 2: Approximation of CCR5 populations.
    Zhang J; Fu Y; Li G; Zhao RY; Lakowicz JR
    Biochem Biophys Res Commun; 2011 Apr; 407(1):63-7. PubMed ID: 21356199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescent avidin-bound silver particle: a strategy for single target molecule detection on a cell membrane.
    Zhang J; Fu Y; Liang D; Zhao RY; Lakowicz JR
    Anal Chem; 2009 Feb; 81(3):883-9. PubMed ID: 19113832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding.
    Wu L; LaRosa G; Kassam N; Gordon CJ; Heath H; Ruffing N; Chen H; Humblias J; Samson M; Parmentier M; Moore JP; Mackay CR
    J Exp Med; 1997 Oct; 186(8):1373-81. PubMed ID: 9334377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5.
    Olson WC; Rabut GE; Nagashima KA; Tran DN; Anselma DJ; Monard SP; Segal JP; Thompson DA; Kajumo F; Guo Y; Moore JP; Maddon PJ; Dragic T
    J Virol; 1999 May; 73(5):4145-55. PubMed ID: 10196311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes.
    Moulard M; Phogat SK; Shu Y; Labrijn AF; Xiao X; Binley JM; Zhang MY; Sidorov IA; Broder CC; Robinson J; Parren PW; Burton DR; Dimitrov DS
    Proc Natl Acad Sci U S A; 2002 May; 99(10):6913-8. PubMed ID: 11997472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple CCR5 conformations on the cell surface are used differentially by human immunodeficiency viruses resistant or sensitive to CCR5 inhibitors.
    Berro R; Klasse PJ; Lascano D; Flegler A; Nagashima KA; Sanders RW; Sakmar TP; Hope TJ; Moore JP
    J Virol; 2011 Aug; 85(16):8227-40. PubMed ID: 21680525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescent metal nanoshell and CK19 detection on single cell image.
    Zhang J; Fu Y; Li G; Lakowicz JR; Zhao RY
    Biochem Biophys Res Commun; 2011 Sep; 413(1):53-7. PubMed ID: 21867692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of the extracellular domains of C-C chemokine receptor 5 and the in vitro effects on simian immunodeficiency virus or HIV infectivity.
    Lehner T; Doyle C; Wang Y; Babaahmady K; Whittall T; Tao L; Bergmeier L; Kelly C
    J Immunol; 2001 Jun; 166(12):7446-55. PubMed ID: 11390497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function.
    Lee B; Sharron M; Blanpain C; Doranz BJ; Vakili J; Setoh P; Berg E; Liu G; Guy HR; Durell SR; Parmentier M; Chang CN; Price K; Tsang M; Doms RW
    J Biol Chem; 1999 Apr; 274(14):9617-26. PubMed ID: 10092648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4 and CCR5 constitutively interact at the plasma membrane of living cells: a confocal fluorescence resonance energy transfer-based approach.
    Gaibelet G; Planchenault T; Mazères S; Dumas F; Arenzana-Seisdedos F; Lopez A; Lagane B; Bachelerie F
    J Biol Chem; 2006 Dec; 281(49):37921-9. PubMed ID: 17035237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors.
    Catani MV; Corasaniti MT; Navarra M; Nisticò G; Finazzi-Agrò A; Melino G
    J Neurochem; 2000 Jun; 74(6):2373-9. PubMed ID: 10820198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of an unique CXCR4 epitope whose ligation inhibits infection by both CXCR4 and CCR5 tropic human immunodeficiency type-I viruses.
    Adachi T; Tanaka R; Kodama A; Saito M; Takahashi Y; Ansari AA; Tanaka Y
    Retrovirology; 2011 Oct; 8():84. PubMed ID: 22018245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
    Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE
    J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent antiviral synergy between monoclonal antibody and small-molecule CCR5 inhibitors of human immunodeficiency virus type 1.
    Murga JD; Franti M; Pevear DC; Maddon PJ; Olson WC
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3289-96. PubMed ID: 17005807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2G12 as probed by Fc-tagged gp120.
    Binley JM; Ngo-Abdalla S; Moore P; Bobardt M; Chatterji U; Gallay P; Burton DR; Wilson IA; Elder JH; de Parseval A
    Retrovirology; 2006 Jul; 3():39. PubMed ID: 16817962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of HIV type 2 primary isolates to CCR5 and CXCR4 monoclonal antibodies, ligands, and small molecule inhibitors.
    Espirito-Santo M; Santos-Costa Q; Calado M; Dorr P; Azevedo-Pereira JM
    AIDS Res Hum Retroviruses; 2012 May; 28(5):478-85. PubMed ID: 21902586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad-spectrum inhibition of HIV-1 by a monoclonal antibody directed against a gp120-induced epitope of CD4.
    Burastero SE; Frigerio B; Lopalco L; Sironi F; Breda D; Longhi R; Scarlatti G; Canevari S; Figini M; Lusso P
    PLoS One; 2011; 6(7):e22081. PubMed ID: 21818294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR5 susceptibility to ligand-mediated down-modulation differs between human T lymphocytes and myeloid cells.
    Fox JM; Kasprowicz R; Hartley O; Signoret N
    J Leukoc Biol; 2015 Jul; 98(1):59-71. PubMed ID: 25957306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells.
    Singer II; Scott S; Kawka DW; Chin J; Daugherty BL; DeMartino JA; DiSalvo J; Gould SL; Lineberger JE; Malkowitz L; Miller MD; Mitnaul L; Siciliano SJ; Staruch MJ; Williams HR; Zweerink HJ; Springer MS
    J Virol; 2001 Apr; 75(8):3779-90. PubMed ID: 11264367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.